SULFATRIM Side Effects

7027066-7 | Hypokalaemia, Syncope
on Sep 21, 2010 Female patient from DENMARK , 62 years of age, was diagnosed with hypertension and was treated with Sulfatrim (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, syncope. Sulfatrim dosage: Qam;po. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

7020446-5 | Abnormal Behaviour, Agitation, Confusional State, Muscle Twitching, Tremor
Patient was taking Sulfatrim (View Usage). Patient had the following side effects: abnormal behaviour, agitation, confusional state, muscle twitching, tremor on Sep 15, 2010 from DENMARK Additional patient health information: Male patient , 59 years of age, was diagnosed with pneumocystis jiroveci pneumonia and. Sulfatrim dosage: 3840 Mg;bid; Iv. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), ARANESP (View Aranesp Review and Aranesp Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), CALCICHEW (View Calcichew Review and Calcichew Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ).

7020438-6 | Dyspnoea, Eye Swelling, Hypertension, Lung Infiltration, Rash Maculo-papular
Adverse event was reported on Sep 15, 2010 by a Male patient taking Sulfatrim (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: DENMARK , 54 years of age, After Sulfatrim was administered, patient had the following side effects: dyspnoea, eye swelling, hypertension, lung infiltration, rash maculo-papular. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), TAMSULOSIN (View Tamsulosin Review and Tamsulosin Label ).

7019809-3 | Confusional State, Paranoia, Psychotic Disorder
on Sep 14, 2010 Female patient from UNITED KINGDOM , 35 years of age, was diagnosed with pneumocystis jiroveci pneumonia and was treated with Sulfatrim (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, paranoia, psychotic disorder (What is psychotic disorder?). Sulfatrim dosage: 1800 Mg;bid;iv. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CELL CEPT (View Cell Cept Review and Cell Cept Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CALCICHEW (View Calcichew Review and Calcichew Label ).


6945972-6 | Arthropathy, Biliary Tract Disorder, Blood Triglycerides Increased, Cardiac Disorder, Chills, Dermatitis, Dermatitis Exfoliative, Epidermal Necrosis, Face Oedema
on Aug 11, 2010 Male patient from FRANCE , 31 years of age, was treated with Sulfatrim (View Usage). Patient had the following side effects: arthropathy, biliary tract disorder, blood triglycerides increased, cardiac disorder, chills, dermatitis, dermatitis exfoliative, epidermal necrosis, face oedema. Sulfatrim dosage: . Patient was hospitalized.

6491129-5 | Cardiomyopathy
Patient was taking Sulfatrim (View Usage). After Sulfatrim was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?) on Nov 25, 2009 from DENMARK Additional patient health information: Female patient , 53 years of age, . Sulfatrim dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ). Patient was hospitalized.

6465014-9 | Stevens-johnson Syndrome
Adverse event was reported on Nov 09, 2009 by a Female patient taking Sulfatrim (View Usage) (Dosage: ) was diagnosed with upper respiratory tract infection and. Location: NIGERIA , child 10 years of age, Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. During the same period patient was treated with FANSIDAR (View Fansidar Review and Fansidar Label ). Patient was hospitalized.

6465013-7 | Stevens-johnson Syndrome, Toxic Epidermal Necrolysis
on Nov 09, 2009 Male patient from NIGERIA , 14 years of age, was diagnosed with malaria (What is malaria?) and was treated with Sulfatrim (View Usage). Patient had the following side effects: stevens-johnson syndrome, toxic epidermal necrolysis. Sulfatrim dosage: . Patient was hospitalized.

6465001-0 | Skin Hypopigmentation, Stevens-johnson Syndrome, Toxic Epidermal Necrolysis
on Nov 09, 2009 Female patient from NIGERIA , child 7 years of age, was diagnosed with upper respiratory tract infection and was treated with Sulfatrim (View Usage). After Sulfatrim was administered, patient had the following side effects: skin hypopigmentation, stevens-johnson syndrome, toxic epidermal necrolysis. Sulfatrim dosage: . Patient was hospitalized.

5605583-1 | Rash
Patient was taking Sulfatrim (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?) on Jan 25, 2008 from UNITED STATES Additional patient health information: Female patient , child 4 years of age, weighting 47.18 lb, . Sulfatrim dosage: One Tsp Bid Po.